2. Saccharides
  3. Glycolipids

Glycolipids

Glycolipids (47):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-112174
    UDP-GlcNAc disodium 91183-98-1 99.92%
    UDP-GlcNAc Disodium Salt (UDP-α-D-N-Acetylglucosamine Disodium Salt) is a donor substrate of O-GlcNAc transferase (OGT).
    UDP-GlcNAc disodium
  • HY-102022
    α-Galactosylceramide 158021-47-7
    α-Galactosylceramide (α-GalCer) is a synthetic glycolipid with antitumorial and immunostimulatory. α-Galactosylceramide is a very potent NKT cell agonist and binds effectively to CD1d. The complex of α-Galactosylceramide plus CD1d binds the NKT cell TCR (T cell antigen receptor).
    α-Galactosylceramide
  • HY-N7745
    Glucosylsphingosine 52050-17-6 99.68%
    Glucosylsphingosine (lyso-Gb1) is a deacylated form of glucosylceramide with neurotoxicity and is also a noncompetitively inhibitor of glucocerebrosidase with a Ki value of 30 μM. Glucosylsphingosine is promising for research of Krabbe and Gaucher disease.
    Glucosylsphingosine
  • HY-114456
    Ganglioside GM3 124579-05-1 99.42%
    Ganglioside GM3 is a precursor of a-, b-, and c-series gangliosides, interacts with transmembrane receptors such as the epidermal growth factor and insulin receptors, and regulates receptor functions by creating a specialized lipid environment. Ganglioside GM3 is synthesized by GM3 synthase and can be used for the research of hypercholesterolemia.
    Ganglioside GM3
  • HY-136490
    Psychosine 2238-90-6 99.9%
    Psychosine (Galactosylsphingosine), a substrate of the galactocerebrosidase (GALC) enzyme, is a potential biomarker for Krabbe disease. Psychosine is a highly cytotoxic lipid, capable of inducing cell death in a wide variety of cell types including, most relevantly to globoid cell leukodystrophy (GLD), oligodendrocytes. Psychosine causes cell death at least in part via apoptosis. Psychosine also is an inhibitor of PKC.
    Psychosine
  • HY-148747
    Ganglioside GD3 (d18:1/12:0) 138749-26-5
    Ganglioside GD3 (d18:1/12:0) is a type of glycosphingolipid, the d18:1 indicates the sphingosine base, and the 12:0 represents the fatty acid part which is lauric acid. Ganglioside GD3 (d18:1/12:0) is a crucial intermediate in the biosynthesis pathway of gangliosides and is mainly found in the brain tissues of mammals. Ganglioside GD3 (d18:1/12:0) plays significant roles in development, cell signal transduction, and various diseases.
    Ganglioside GD3 (d18:1/12:0)
  • HY-153830
    LacCer (d18:1/16:0) 4201-62-1 99%
    LacCer (d18:1/16:0) (C16 Lactosylceramide (d18:1/16:0)) is an endogenous bioactive sphingolipid that can form membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs). The levels of LacCer (d18:1/16:0) are elevated in the plasma of insulin-resistant cattle. In a mouse model of Niemann-Pick type C1 disease (a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder), the expression of LacCer (d18:1/16:0) is also upregulated. LacCer (d18:1/16:0) can be used in research on metabolic diseases and neurodegenerative diseases.
    LacCer (d18:1/16:0)
  • HY-N10634
    D-Glucosyl-β-1,1′-N-palmitoylsphingosine 74365-77-8 99.30%
    D-Glucosyl-β-1,1′-N-palmitoylsphingosine (C16 Glucosyl (β) Ceramide (d18:1/16:0)) is an endogenous Mincle ligand with immunostimulatory activity. D-Glucosyl-β-1,1′-N-palmitoylsphingosine binds to and activates macrophage-inducible C-type lectin (Mincle). D-Glucosyl-β-1,1′-N-palmitoylsphingosine is applicable to the research of immune system diseases.
    D-Glucosyl-β-1,1′-N-palmitoylsphingosine
  • HY-N3570
    Cerebroside B 88642-46-0 98%
    Cerebroside B, a sphingolipid compound, is a non-racespecific elicitor, which elicits defense responses in rice.
    Cerebroside B
  • HY-W341625
    Trihexosylceramide (d18:1/12:0) 474943-80-1 99.28%
    Trihexosylceramide (d18:1/12:0) is a glycosphingolipid and mood-related compound. Trihexosylceramide (d18:1/12:0) is characterized by elevated serum levels in Mus musculus fed a high-fat diet, and its levels are positively correlated with mood Z-scores. Accumulation of Trihexosylceramide (d18:1/12:0) in tissues is considered the etiology of angiokeratoma corporis diffusum. Trihexosylceramide (d18:1/12:0) can be used in studies related to high-fat diet-induced mood disorders.\n
    Trihexosylceramide (d18:1/12:0)
  • HY-N8515C
    UDP-3-O-acyl-GlcNAc disodium
    UDP-3-O-acyl-GlcNAc (UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine) disodium is an E. coli metabolite that is involved in 3-deoxy-D-manno-octulosonate (KDO) biosynthesis pathway.
    UDP-3-O-acyl-GlcNAc disodium
  • HY-125726
    Sulfo galactosylceramide 151057-28-2 98%
    Sulfo galactosylceramide (N-Nervonoyl Sulfatide; C24:1 Sulfatide) is a glycolipid and the major sulfolipid species in mature myelin. Sulfo galactosylceramide interacts with C-type lectins and immunoglobulin-like receptors, with the highest affinity for LMIR5. Sulfo galactosylceramide induces MCP-1 production by basophils but not mast cells, and increases NFAT activation via LMIR5. Sulfo galactosylceramide alleviates symptoms and improves survival in a mouse model of chronic relapsing-remitting experimental autoimmune encephalomyelitis (EAE), and reduces inflammatory lesions and the number of infiltrating mononuclear cells in the lumbar spinal cord of EAE mice.
    Sulfo galactosylceramide
  • HY-N15905
    C20 Glucosyl(β) ceramide (d18:1/20:0) 119242-43-2 99%
    C20 Glucosyl(β) ceramide (d18:1/20:0) is a β-glucosyl ceramide.
    C20 Glucosyl(β) ceramide (d18:1/20:0)
  • HY-W585865
    UDP-3-O-acyl-GlcNAc Tris 112710-84-6
    UDP-3-O-acyl-GlcNAc (UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine) Tris is an E. coli metabolite that is involved in 3-deoxy-D-manno-octulosonate (KDO) biosynthesis pathway.
    UDP-3-O-acyl-GlcNAc Tris
  • HY-N8515
    UDP-3-O-acyl-GlcNAc 108636-29-9
    UDP-3-O-acyl-GlcNAc (UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine) is an E. coli metabolite that is involved in 3-deoxy-D-manno-octulosonate (KDO) biosynthesis pathway.
    UDP-3-O-acyl-GlcNAc
  • HY-153860
    LacCer (d18:1/20:0) 125650-87-5 99.94%
    LacCer (d18:1/20:0) is a lipid whose level is closely associated with atherosclerosis and cardiovascular diseases.
    LacCer (d18:1/20:0)
  • HY-177888
    Lc2Cer(d18:1, 22:0) 111142-68-8 98.0%
    Lc2Cer(d18:1, 22:0) is a lactosylceramide containing d18:1, C22:0 ceramides. Lc2Cer(d18:1, 22:0) can be used for renal cortical epithelial cell research.
    Lc2Cer(d18:1, 22:0)
  • HY-N10636
    D-lactosyl-β-1,1′ N-stearoyl-D-erythro-sphingosine 125712-73-4 98.82%
    D-lactosyl-β-1,1′ N-stearoyl-D-erythro-sphingosine is a neutral glycolipid.
    D-lactosyl-β-1,1′ N-stearoyl-D-erythro-sphingosine
  • HY-N17233
    LacCer(d18:1/24:0) 105087-85-2
    LacCer(d18:1/24:0) is a lipid. LacCer(d18:1/24:0) can be found in plasma. LacCer(d18:1/24:0) is associated with critical illness after cardiac surgery.
    LacCer(d18:1/24:0)
  • HY-N15820
    C18:0 GM1(Neu5Gc) Ceramide (d18:1/18:0) 3056013-75-0
    C18:0 GM1(Neu5Gc) Ceramide (d18:1/18:0) is a ganglioside.
    C18:0 GM1(Neu5Gc) Ceramide (d18:1/18:0)